Special Issue "Pathogen Legionella pneumophila"
A special issue of Pathogens (ISSN 2076-0817).
Deadline for manuscript submissions: closed (30 September 2016).
Interests: drug design; metalloenzymes; carbonic anhydrases, anticancer agents; antiinfectives; sulfonamides; coumarins
Special Issues and Collections in MDPI journals
Special Issue in Metabolites: Cancer Metabolomics 2016
Special Issue in International Journal of Molecular Sciences: Enzyme-Inhibitor Interaction as Examples of Molecular Recognition
Special Issue in Molecules: Sulfonamides
Special Issue in Metabolites: Carbonic Anhydrases and Metabolism
Special Issue in Marine Drugs: Carbonic Anhydrase in Marine Organism
Special Issue in Molecules: Metalloenzyme Inhibitors and Activators
Special Issue in International Journal of Molecular Sciences: Protease and Carbonic Anhydrase Inhibitors and Their Roles in Pathological Processes
Special Issue in Metabolites: Carbonic Anhydrases and Metabolism Volume 2
Topical Collection in International Journal of Molecular Sciences: 20th Anniversary of IJMS: Advances in Biochemistry
Special Issue in International Journal of Molecular Sciences: Protease and Carbonic Anhydrase Inhibitors, II
Special Issue in International Journal of Molecular Sciences: Biochemistry, Molecular Biology and Druggability of Proteins
Special Issue in Metabolites: Metabolism in the Tumor Microenvironment
Legionella pneumophila is a Gram-negative environmental bacterium that normally infects amoebae. It was discovered in 1976 when it provoked a life-threatening pneumonia-like disease in many participants at the 58th Annual Convention of the American Legion in Philadelphia. This condition was subsequently dubbed Legionnaires’ disease, or legionellosis. When the bacterial pathogen was characterized in detail, it was shown that a large number of its subspecies and serovars are widespread in nature. It is now known that L. pneumophila and the related species L. longbeachae are responsible for legionellosis in humans. These pathogens are increasingly spread all over the world through the development of artificial water systems for air conditioning, cooling towers, and aerosolizing devices, among other applications, and they have started to show resistance to the clinically used antibiotics. This issue of the Pathogens will bring together papers in all fields, starting with molecular biology and ending with novel antibiotic development related to L. pneumophila.
Professor Claudiu T. Supuran
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Legionella pneumophila
- drug resistance
- bacterial evolution
- pathogen survival
- drug development